Aurisco PharmaceuticalLtd Management
Management criteria checks 2/4
Aurisco PharmaceuticalLtd's CEO is Dingjun Chu, appointed in Jun 2017, has a tenure of 7.42 years. directly owns 0.81% of the company’s shares, worth CN¥69.72M. The average tenure of the management team and the board of directors is 7.4 years and 7.4 years respectively.
Key information
Dingjun Chu
Chief executive officer
CN¥1.7m
Total compensation
CEO salary percentage | n/a |
CEO tenure | 7.4yrs |
CEO ownership | 0.8% |
Management average tenure | 7.4yrs |
Board average tenure | 7.4yrs |
Recent management updates
Recent updates
CEO
Dingjun Chu (51 yo)
7.4yrs
Tenure
CN¥1,713,284
Compensation
Mr. Dingjun Chu is General Manager and Director of Aurisco Pharmaceutical Co.,Ltd. since June 01, 2017.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Director | 7.4yrs | CN¥1.71m | 0.81% CN¥ 69.7m | |
Deputy GM & Director of Sales | 7.4yrs | CN¥1.29m | 0.044% CN¥ 3.8m | |
Deputy GM & Director | 7.4yrs | CN¥1.75m | no data | |
Board Secretary | 7.4yrs | CN¥1.13m | no data | |
Deputy General Manager | 6.7yrs | CN¥906.76k | 0.062% CN¥ 5.3m |
7.4yrs
Average Tenure
51yo
Average Age
Experienced Management: 605116's management team is seasoned and experienced (7.4 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Director | 7.4yrs | CN¥1.71m | 0.81% CN¥ 69.7m | |
Deputy GM & Director | 4.5yrs | CN¥1.75m | no data | |
Vice Chairman | 7.4yrs | CN¥76.12k | 31.71% CN¥ 2.7b | |
Chairman of the Board | 7.4yrs | CN¥1.36m | 37.81% CN¥ 3.2b | |
Director | 7.4yrs | CN¥1.08m | 2.75% CN¥ 236.1m | |
Chairman of the Supervisory Board | 7.4yrs | no data | 0.81% CN¥ 69.7m | |
Supervisor | 7.4yrs | no data | no data |
7.4yrs
Average Tenure
58yo
Average Age
Experienced Board: 605116's board of directors are considered experienced (7.4 years average tenure).